Andrea K. Kerrigan, FDA, outlines how validation, data integrity, and QRM determine whether digital tools and AI strengthen or undermine CGMP compliance.
|Articles|July 2, 2014
- Pharmaceutical Technology-07-02-2014
- Volume 38
- Issue 7
Sieve Shakers Ensure Reliability
Author(s)Melanie Sena
Sieve Shakers Ensure Reliability
FRITSCH offers a range of sieve shakers for dry, wet, and micro-precision sieving. The three different sieves can be used for measuring the quantitative particle size distribution of solids and suspensions. For high performance sieving, the ANALYSETTE 3 Pro has an electromagnetic drive that oscillates sieve stacks into regulated vertical oscillations and can be used in sample quantities up to 2 kg and a measurement range from 5 μm to 63 mm. For typical sieving tasks, the ANALYSETTE 3 Spartan includes the FRITSCH sieve stack tensioning system EASYTWIST and the FRITSCH evaluation software AUTOSIEVE for evaluation of the sieve analysis. For sieving large quantites, FRITSCH offers the ANALYSETTE 18, which can sieve up to 15 kg of material between 20 μm and 125 mm. The three-dimensional sieving motion ensures fast sieving results without manual re-sieving.
Articles in this issue
about 12 years ago
Trends in Manufacturing and Equipmentabout 12 years ago
The Mainstreaming of Continuous Flow API Synthesisabout 12 years ago
Health Systems Raise the Bar on Reimbursing New Drugsabout 12 years ago
Data Integrityabout 12 years ago
Environmental Monitoring System Improves Efficiencyabout 12 years ago
Automating Online Sampling of Bioprocessesabout 12 years ago
Laboratory Filter-Dryer Enables Scalabilityabout 12 years ago
Sterilization of Blow-Fill-Seal Equipment for Aseptic FillingRelated to this article
PharmTech spoke with Tara Dougal, event director for pharma at Informa Markets, about trends impacting the pharmaceutical industry and how CPHI Milan is addressing these areas this year.
Andrew Parker, PhD, executive drug development consultant, Quotient Sciences, explains how AI is integrated into pharmaceutical development.
PDA/FDA 2026 session maps the GMP audit lifecycle, root cause to CAPA closure, plus a local vs. above-site decision framework and two case studies.
The recently opened NJ spray drying facility doubles capacity for amorphous solid dispersions, addressing solubility limits in roughly 70% of small-molecule pipelines.
Lori Dingledine, QC Director Microbiological Control and GTIC Operations at Genentech, provided input on the regulations surrounding raw material manufacturing and use for ATMPs in a presentation at the 2026 PDA/FDA Joint Regulatory Conference.
FDA opens applications for its Expedited IND Pilot, pairing sponsors with qualified research institutions to test rolling CMC review ahead of first-in-human trials.
2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.